One such startup is CASPR Biotech from Argentina.

And the startup recently stated that it’s developed a prototype of its molecular diagnosis kit to identify pathogen 2019-nCOv.

According to the biotech, it can diagnose the virus quickly, even if the person hasn’t shown symptoms and at a very low cost.

In this case, the biotech configures its kit to identify the coronavirus at a molecular level.

But it appears the CASPR Biotech team is working on it. | To read full story, visit https://startuparound.com/read/1581789609.6629739/CASPR-Biotech-developed-a-prototype-to-quickly-diagnose-coronavirus?ref=audio_experience